Glasgow-based Solasta Bio, an agri-biotech company specialising in the next generation of green insecticides, announced two significant developments that accelerate its path to regulatory approval and commercialisation.

The company has received its first patent grant, a critical milestone that protects its innovative technology and strengthens its intellectual property portfolio. Additional patents are expected to follow, reinforcing Solasta Bio’s position as a leader in sustainable pest control solutions.

Additionally, Solasta Bio secured a favourable biochemical-like classification from the U.S. Environmental Protection Agency (EPA) for its lead peptide candidates. This classification is a major regulatory win, streamlining the approval process and validating the company’s novel approach to bioinsecticides. The EPA’s recognition highlights the company’s commitment to delivering highly effective, environmentally friendly alternatives to traditional chemical pesticides.

These achievements build on Solasta Bio’s growing momentum following an oversubscribed $14 million Series A funding round in September 2024. The successful funding round demonstrated strong investor confidence in the company’s mission and technology.

The round attracted leading agricultural and life science investors, including Forbion BioEconomy Fund, FMC Ventures, and Corteva Catalyst. Their investment underscores the industry’s belief in Solasta Bio’s ability to revolutionize pest management with its next-generation green insecticides.

Solasta Bio’s technology focuses on developing biodegradable peptide-based insecticides that target pests with high precision while minimizing environmental impact. Unlike conventional pesticides, which can cause unintended harm to beneficial insects and ecosystems, Solasta Bio’s solutions are designed to be highly selective and break down naturally, ensuring long-term sustainability.

With the combination of strong intellectual property protection, regulatory advancements, and robust financial backing, Solasta Bio is well-positioned to accelerate the commercialisation of its groundbreaking bioinsecticides. The company continues to work closely with regulatory agencies, investors, and industry partners to bring its innovative solutions to market and contribute to a more sustainable future for agriculture.

source – solastabio